open access

Vol 4, No 2 (2003): Practical Diabetology
Original articles (submitted)
Published online: 2003-04-28
Get Citation

The DINAMIC 2 results in Poland (II)

Jacek Sieradzki, Teresa Kasperska-Czyżyk, Władysław Grzeszczak, Marcin Szczepański oraz Zespół Badaczy DINAMIC
Diabetologia Praktyczna 2003;4(2):103-110.

open access

Vol 4, No 2 (2003): Practical Diabetology
Original articles (submitted)
Published online: 2003-04-28

Abstract

The aim of the study was to evaluate the results of complex treatment including education, self-control, normalisation of glycemia and blood pressure in patients with type 2 diabetes. We also analysed modes of treatment and pharmacotherapy. The study population consisted of 2636 patients randomly chosen in 293 offices of family physicians all over Poland. Of them 59.48% underwent education whereas 33.27% implemented self-control. Most diabetic patients (52.24%) received one oral agent, which was most frequently gliklazyd (58.95%). Mean HbA1c for the whole country was 7.37%, and 45.71% of patients had their HbA1c up to 7%. Slight differences favouring the educated and self-controlled group were seen only with respect to the level of HbA1c. Arterial hypertension was found in 56.7% and 66.2% received treatment lowering blood pressure. Only 5.16% had their arterial blood pressure below 130/80 mm Hg. Of antihypertensive agents ACE inhibitors were most frequently used.
Of note is a large proportion of patients who did not fulfil the criteria of diabetes control. As for the level of HbA1c the results in Poland are not bad as compared with other countries. Of concern is a small emphasis on hypertension treatment. Summing up, it should be noted that not only multifactorial approach to treatment of type 2 diabetes is important, but also it is necessary to take into account carbohydrate and lipid parameters, and first of all blood pressure control.

Abstract

The aim of the study was to evaluate the results of complex treatment including education, self-control, normalisation of glycemia and blood pressure in patients with type 2 diabetes. We also analysed modes of treatment and pharmacotherapy. The study population consisted of 2636 patients randomly chosen in 293 offices of family physicians all over Poland. Of them 59.48% underwent education whereas 33.27% implemented self-control. Most diabetic patients (52.24%) received one oral agent, which was most frequently gliklazyd (58.95%). Mean HbA1c for the whole country was 7.37%, and 45.71% of patients had their HbA1c up to 7%. Slight differences favouring the educated and self-controlled group were seen only with respect to the level of HbA1c. Arterial hypertension was found in 56.7% and 66.2% received treatment lowering blood pressure. Only 5.16% had their arterial blood pressure below 130/80 mm Hg. Of antihypertensive agents ACE inhibitors were most frequently used.
Of note is a large proportion of patients who did not fulfil the criteria of diabetes control. As for the level of HbA1c the results in Poland are not bad as compared with other countries. Of concern is a small emphasis on hypertension treatment. Summing up, it should be noted that not only multifactorial approach to treatment of type 2 diabetes is important, but also it is necessary to take into account carbohydrate and lipid parameters, and first of all blood pressure control.
Get Citation

Keywords

DINAMIC 2; diabetes type 2; glycaemic control

About this article
Title

The DINAMIC 2 results in Poland (II)

Journal

Clinical Diabetology

Issue

Vol 4, No 2 (2003): Practical Diabetology

Pages

103-110

Published online

2003-04-28

Bibliographic record

Diabetologia Praktyczna 2003;4(2):103-110.

Keywords

DINAMIC 2
diabetes type 2
glycaemic control

Authors

Jacek Sieradzki
Teresa Kasperska-Czyżyk
Władysław Grzeszczak
Marcin Szczepański oraz Zespół Badaczy DINAMIC

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl